Pharmaceuticals.jpg

Pharmaceuticals

Contamination by human and veterinary pharmaceutical derivatives refers to the undesirable presence of drug residues in the environment, including water, soil, and living organisms. This contamination can occur at various stages, including production, consumption, and disposal of medications. Main sources include releases from pharmaceutical facilities, wastewater discharges containing drug residues, and uncontrolled use of veterinary drugs in agriculture. Pharmaceutical contamination raises environmental and health concerns, impacting ecosystems and posing risks of antibiotic-resistant bacteria emergence. Conventional wastewater treatment methods may not efficiently remove these compounds, contributing to their persistence. Efforts are underway to develop advanced treatment technologies and sustainable pharmaceutical waste management practices. Regulations aim to limit releases and promote environmental monitoring to assess the extent of contamination by pharmaceutical derivatives.

519-98-2

4-Methylamino Antipyrine

519-98-2
856307-27-2

4-Methylaminoantipyrine HCl

856307-27-2
479-98-1

Aucubin

479-98-1
21293-29-8

(S)-(+)-Abscisic Acid

21293-29-8
1421760-64-6

2-Hydroxy Atorvastatin 2H2O Monosodium Salt

1421760-64-6
1276537-18-8

4-Hydroxy Atorvastatin 2H2O Monosodium Salt

1276537-18-8
65490-24-6

Anhydro chlortetracycline HCl

65490-24-6
13803-65-1

Anhydro tetracycline HCl

13803-65-1
503612-47-3

Apixaban

503612-47-3
503614-92-4

Apixaban Acid

503614-92-4
88150-42-9

Amlodipine

88150-42-9
521-18-6

5alpha-Dihydrotestosterone

521-18-6
503614-91-3

Apixaban Ester

503614-91-3
54965-21-8

Albendazole

54965-21-8
53-41-8

Androsterone

53-41-8
11051-71-1

Avilamycin

11051-71-1
117-37-3

Anisindione

117-37-3
645-05-6

Altretamine

645-05-6
58579-51-4

Anagrelide HCl

58579-51-4
123524-52-7

Azelnidipine

123524-52-7